Real-world effectiveness and clinical predictors of response to first-generation TTR silencers in variant ATTR amyloidosis with polyneuropathy

M. A. Ribot-Sansó, J. González-Moreno, C. Bayon-González, C. Borrachero-Garro, S. García-Garrido, F. Muñoz-Beamud, C. Casasnovas-Pons, A. Alejaldre, A. Antón-Vicente, T. Sevilla, R. Fernández-Torrón, S. Kapetanovic-García, L. Galan, D. Heine-Suñer, M. Ventayol-Guirado, R. Eiros, F. Martínez-Valle, P. Hernández-Sanjuán, I. Losada-López, Eugenia Cisneros-Barroso

Open source

DOI: 10.1038/s41598-026-62140-y
Published: 2026-07-15
Container: Scientific Reports
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-026-62140-y,
  title = {Real-world effectiveness and clinical predictors of response to first-generation TTR silencers in variant ATTR amyloidosis with polyneuropathy},
  author = {M. A. Ribot-Sansó and J. González-Moreno and C. Bayon-González and C. Borrachero-Garro and S. García-Garrido and F. Muñoz-Beamud and C. Casasnovas-Pons and A. Alejaldre and A. Antón-Vicente and T. Sevilla and R. Fernández-Torrón and S. Kapetanovic-García and L. Galan and D. Heine-Suñer and M. Ventayol-Guirado and R. Eiros and F. Martínez-Valle and P. Hernández-Sanjuán and I. Losada-López and Eugenia Cisneros-Barroso},
  year = {2026},
  journal = {Scientific Reports},
  doi = {10.1038/s41598-026-62140-y},
  url = {https://doi.org/10.1038/s41598-026-62140-y}
}

RIS

TY  - JOUR
TI  - Real-world effectiveness and clinical predictors of response to first-generation TTR silencers in variant ATTR amyloidosis with polyneuropathy
AU  - M. A. Ribot-Sansó
AU  - J. González-Moreno
AU  - C. Bayon-González
AU  - C. Borrachero-Garro
AU  - S. García-Garrido
AU  - F. Muñoz-Beamud
AU  - C. Casasnovas-Pons
AU  - A. Alejaldre
AU  - A. Antón-Vicente
AU  - T. Sevilla
AU  - R. Fernández-Torrón
AU  - S. Kapetanovic-García
AU  - L. Galan
AU  - D. Heine-Suñer
AU  - M. Ventayol-Guirado
AU  - R. Eiros
AU  - F. Martínez-Valle
AU  - P. Hernández-Sanjuán
AU  - I. Losada-López
AU  - Eugenia Cisneros-Barroso
PY  - 2026
JO  - Scientific Reports
DO  - 10.1038/s41598-026-62140-y
UR  - https://doi.org/10.1038/s41598-026-62140-y
ER  -

APA

Ribot-Sansó, M. A., González-Moreno, J., Bayon-González, C., Borrachero-Garro, C., García-Garrido, S., Muñoz-Beamud, F., Casasnovas-Pons, C., Alejaldre, A., Antón-Vicente, A., Sevilla, T., Fernández-Torrón, R., Kapetanovic-García, S., Galan, L., Heine-Suñer, D., Ventayol-Guirado, M., Eiros, R., Martínez-Valle, F., Hernández-Sanjuán, P., Losada-López, I., & Cisneros-Barroso, E. (2026). Real-world effectiveness and clinical predictors of response to first-generation TTR silencers in variant ATTR amyloidosis with polyneuropathy. Scientific Reports. https://doi.org/10.1038/s41598-026-62140-y

Source records

crossref · retrieved 2026-09-26T21:23:21.752Z